Newly Developed RSV Vaccine Offers Immunity While Lowering the Risk of Dangerous Pulmonary Inflammation
/PRNewswire/ -- Scientists at Artificial Cell Technologies (ACT) have developed a fully synthetic microparticle vaccine for Respiratory Syncytial Virus (RSV)...